Search Results - "Butler MO"

Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.

Authors: Ribas A Algazi A Ascierto PA et al.

Source: Nature communications [Nat Commun] 2021 Aug 12; Vol. 12 (1), pp. 5022. Date of Electronic Publication: 2021 Aug 12.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE

Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial.

Authors: Icht O Sun A Wong P et al.

Source: Frontiers in oncology [Front Oncol] 2026 Jul 06; Vol. 16, pp. 1841070. Date of Electronic Publication: 2026 Jul 06 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan/Hepatic Delivery System Versus Best Alternative Care for Patients with Metastatic Uveal Melanoma.

Authors: Zager JS John J

Source: Annals of surgical oncology [Ann Surg Oncol] 2025 Aug; Vol. 32 (8), pp. 5404-5405. Date of Electronic Publication: 2025 Jun 12.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process

In silico clinical trials of BiTE expression by oncolytic viruses reveal the impact of patient heterogeneity on dosage protocol.

Authors: Jenner, Adrianne L. Araujo, Robyn P. Levi, Noa L. et al.

Source: PLoS Computational Biology. 7/30/2026, Vol. 22 Issue 7, p1-24. 24p.

Immunotherapy in Melanoma: A Dynamic Frontier in Cancer Treatment : Author List.

Authors: Ahmed A Alahmadi M Khawaji Z et al.

Source: Current treatment options in oncology [Curr Treat Options Oncol] 2026 Jan 19; Vol. 27 (1), pp. 8. Date of Electronic Publication: 2026 Jan 19.

Publication Type: Journal Article; Review

Journal Info: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

CaSMO Recommendations for Prevention and Treatment of Cutaneous Adverse Events Related to Cancer Therapies in Darker Skin Phototypes.

Authors: Fournier C Sauder MB Claveau J et al.

Source: Clinical, cosmetic and investigational dermatology [Clin Cosmet Investig Dermatol] 2025 Dec 19; Vol. 18, pp. 3521-3532. Date of Electronic Publication: 2025 Dec 19 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101543449 Publication Model: eCollection Cited Medium: Print ISSN: 1178-7015 (Print) Linking ISSN: 11787015 NLM ISO Abbreviation: Clin Cosmet Investig Dermatol Subsets: PubMed not MEDLINE

CD28-driven ex vivo generation of stem-like memory CD8⁺ T cells bypassing CD3/TCR signaling.

Authors: Ihara F Ohashi Y Zheng EYF et al.

Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2026 Apr 28; Vol. 123 (17), pp. e2524626123. Date of Electronic Publication: 2026 Apr 21.

Publication Type: Journal Article

Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors.

Authors: Chung DC Ghaedi M Warner K et al.

Source: Oncoimmunology [Oncoimmunology] 2024 May 10; Vol. 13 (1), pp. 2349347. Date of Electronic Publication: 2024 May 10 (Print Publication: 2024).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

Kaposi Sarcoma Associated with Pemphigus Vulgaris in the Setting of Immunosuppressive Therapy: Case Report and Review of Literature.

Authors: Masouri, Hanie Broumand Sani, Sepehr Heidari, Sama et al.

Source: Case Reports in Dermatology. Feb2026, Vol. 18 Issue 1, p199-209. 11p. 2 Illustrations, 1 Chart.

Aggregation-Induced-Emission Luminogens Functionalized MXene Nanosheets for Stimuli-Responsive Hydrogel in Pyroptosis-Mediated Choroidal Melanoma Therapy.

Authors: Xu, Yingni Wang, Fei Liu, Wenfang et al.

Source: Nano-Micro Letters. 3/13/2026, Vol. 18 Issue 1, p1-22. 22p.

GWAS meta-analysis provides new insights into uveal melanoma risk.

Authors: D'Mellow M Wang H Palmer JM et al.

Source: British journal of cancer [Br J Cancer] 2026 Jun 16. Date of Electronic Publication: 2026 Jun 16.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors.

Authors: Dimitriou F Orloff MM Koch Hein EC et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jan; Vol. 214, pp. 115161. Date of Electronic Publication: 2024 Nov 30.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Anti-PGK1 antibodies in immuno-related pancytopenia.

Authors: Hao, Shanfeng Zhang, Yang Xiao, Na et al.

Source: Hematology. Dec2025, Vol. 30 Issue 1, p1-10. 10p.

Afatinib exerts an inhibitory effect on T cell-mediated cytotoxicity.

Authors: Yokomura M Nagano S Kawamoto H et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Jan 03; Vol. 75 (1), pp. 33. Date of Electronic Publication: 2026 Jan 03.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors.

Authors: Hong DS Butler MO Pachynski RK et al.

Source: Frontiers in oncology [Front Oncol] 2022 Mar 18; Vol. 12, pp. 818679. Date of Electronic Publication: 2022 Mar 18 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol.

Authors: Janssen, J. C. van Dijk, B. de Joode, K. et al.

Source: BMC Cancer. 5/23/2024, Vol. 24 Issue 1, p1-7. 7p.

This result is not displayed to guests.
Login for full access.

Case report: Iatrogenic Kaposi sarcoma secondary to Janus kinase and tumor necrosis factor‐alpha inhibitors in rheumatoid arthritis.

Authors: Garza‐Elizondo, Angel Kevin Oscherwitz, Max Cervantes‐Ramirez, Valeria et al.

Source: International Journal of Rheumatic Diseases. Oct2024, Vol. 27 Issue 10, p1-4. 4p.

Structured expert elicitation for long-term survival outcomes in health technology assessment: a systematic review.

Authors: Forsyth, Jessica E. Uttley, Lesley Wong, Ruth et al.

Source: BMC Medical Informatics & Decision Making. 10/21/2025, Vol. 25 Issue 1, p1-11. 11p.

Eosinophilic Fasciitis in a 78-Year-Old Man Following Pembrolizumab Treatment for Bladder Cancer.

Authors: Oke, Ibiyemi Lenert, Aleksander Swick, Brian L. et al.

Source: American Journal of Case Reports. 9/28/2025, Vol. 26, p1-6. 6p.